Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

W 0101 companion diagnostic - Pierre Fabre/Roche

Drug Profile

W 0101 companion diagnostic - Pierre Fabre/Roche

Alternative Names: W-0101 companion diagnostic - Pierre Fabre/Roche

Latest Information Update: 19 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pierre Fabre
  • Developer Pierre Fabre; Roche
  • Class Antibody diagnostics; Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Cancer

Most Recent Events

  • 19 Mar 2021 Phase I/II trial is still ongoing in Cancer in France and Spain (unspecified route) (NCT03316638)
  • 18 May 2018 Phase-I/II clinical trials in Cancer (Diagnosis) in Spain (unspecified route), after March 2018 (NCT03316638)
  • 18 May 2018 Pierre Fabre and Roche extend an earlier agreement to co-develop W 0101 companion diagnostic for Cancer

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top